Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 21, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for April 15, 2005 Subscribe to this News Feed     Subscribe to this Podcast Feed  
 

Beasley Allen Rejects Merck's Attempt to Dismiss the First Vioxx Lawsuit

Montgomery law firm has been named co-lead counsel in all litigation involving the largest drug recall in history.

Montgomery, AL (PRWEB) April 15, 2005 -- Beasley Allen, co-lead counsel for all Vioxx litigation, rejects Merck's attempts to dismiss the first Vioxx case scheduled to go to court in late May, as recorded in The New York Times article of April 13, 2005 entitled, "Merck Asks for Dismissal in First of Suits Over Vioxx."

Beasley Allen is the sole counsel for plaintiff Cheryl Rogers, whose husband, Howard Rogers, died at age 42 as a direct result of taking Vioxx. Merck's contention that Rogers never took the drug directly opposes the evidence Beasley Allen will supply in court.

Merck Asks for Dismissal in First of Suits Over Vioxx.
In response, Jere Beasley, founder and senior partner of Beasley, Allen, Crow, Methvin, Portis & Miles expressed, "Merck's claims are unfounded and are a desperate attempt to avoid a day in court for a victim's family, and account for a drug that is responsible for thousands of deaths. In my opinion, they are trying to force us out of the case by making a most serious accusation against our client."

According to the article, Merck requested dismissal of the first Vioxx personal injury lawsuit scheduled to come to trial May 23, 2005 in the Circuit or State Court of Clay County in Ashland, Ala, case number CV 03-073, Cheryl Rogers V. Merck. Beasley Allen is currently evaluating more than 10,000 Vioxx cases and expects to file hundreds of lawsuits against Merck in the coming months.

"The key issue in the Rogers case is: Did Brad Rogers take Vioxx and did it kill him," Mr. Beasley explained. "We have evidence to prove that he was taking Vioxx before his death. An autopsy proved that the drug caused his death. We know from medical records of Mr. Rogers that he was prescribed Vioxx and that he took Vioxx on a regular basis before his death. We will prove our case in the courtroom."

He added, "Clinical tests have shown Vioxx is a terribly dangerous drug. It has killed literally thousands of unsuspecting victims who trusted the company and who had no idea that Vioxx caused heart attacks and strokes. FDA safety officer Dr. David Graham testified to Congress that taking Vioxx caused over 40,000 deaths."

Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., the Montgomery, Alabama based law firm, has been in the forefront of the effort to have all of the cyclooxygenase-2 (COX-2) inhibitors (Bextra, Celebrex, and Vioxx) taken off the market since the law firm took on its first case against Merck over 4 years ago. Beasley Allen is spearheading the review of over 31,000 claims against the manufacturers of Bextra, Celebrex, and Vioxx, having filed 161 cases to date.

Contact:    
Jere Beasley, Esq.
Beasley Allen
800-898-2034 / 334-451-0814

# # #

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Jere Beasley, Esq.
Beasley, Allen, Crow, Methvin, Portis & Miles
800-898-2034
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright